Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID Trial
06:23pm, Friday, 05'th Mar 2021
SAN FRANCISCO and CINCINNATI, March 5, 2021 /PRNewswire/ -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio Phar
Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q4 2020 Results - Earnings Call Transcript
02:35am, Saturday, 27'th Feb 2021
Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q4 2020 Results - Earnings Call Transcript
Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update
07:31am, Thursday, 25'th Feb 2021
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in th
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in th
Gossamer Bio to Host Webcast Focused on its Inflammatory Bowel Disease Program, GB004, on February 18, 2021
07:05am, Thursday, 04'th Feb 2021
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease
Gossamer Bio to Host Webcast Focused on GB002 and Pulmonary Arterial Hypertension (PAH) on December 15, 2020
07:03am, Monday, 07'th Dec 2020
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in th
Gossamer Bio Announces Appointment of Faheem Hasnain as Chief Executive Officer
07:01am, Monday, 16'th Nov 2020
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease
Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q3 2020 Results - Earnings Call Transcript
11:13pm, Tuesday, 10'th Nov 2020
Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q3 2020 Results - Earnings Call Transcript
Gossamer Bio Announces GB1275 Data Presentations at 2020 Society for Immunotherapy of Cancer Annual Meeting
07:03am, Friday, 06'th Nov 2020
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in th
Gossamer Bio Announces Second Quarter 2020 Financial Results and Provides Corporate Update
08:01pm, Tuesday, 11'th Aug 2020
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflamm
Gossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual Conference
12:31pm, Wednesday, 05'th Aug 2020
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflamm
Could The Gossamer Bio, Inc. (NASDAQ:GOSS) Ownership Structure Tell Us Something Useful?
04:55pm, Wednesday, 22'nd Jul 2020
If you want to know who really controls Gossamer Bio, Inc. (NASDAQ:GOSS), then you'll have to look at the makeup of...
Gossamer Bio's Shares March Higher, Can It Continue?
12:12pm, Wednesday, 22'nd Jul 2020
As of late, it has definitely been a great time to be an investor in Gossamer Bio.
Voloridge Investment Management LLC Takes Position in Gossamer Bio Inc (NASDAQ:GOSS)
07:28am, Saturday, 04'th Jul 2020
Voloridge Investment Management LLC purchased a new stake in Gossamer Bio Inc (NASDAQ:GOSS) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchan
Is Gossamer Bio, Inc. (GOSS) A Good Stock To Buy?
10:27pm, Friday, 03'rd Jul 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
